@Neurosharp

Neuroscientist, Neurologist, Dad, & Network enthusiast - Director of Care Research & Technology Centre, UK Dementia Research Institute

[@Neurosharp @Neurosharp]

What is the UK Dementia Research Institute (UK DRI)? https://t.co/Ufe9pCfKHc via @YouTube

[@Neurosharp @Neurosharp]

How should we describe the distinct features of each traumatic brain injury?
Our ENIGMA collaboration led by Gershon Spitz from Monash shows each TBI patient carries their own “morphologic fingerprint”
New in Neurology: https://t.co/nzU5h0AtGF
@ImperialBrains @UKDRI

[@Neurosharp @Neurosharp]

2/ ZeDTech is a UK-wide network creating zero-burden, sustainable tech to help people with dementia live independently — researchers, clinicians, industry & lived experience together. @UKDRI @ImperialBrains @imperialcollege @EPSRC @alzheimerssoc @NIHRresearch

[@Neurosharp @Neurosharp]

1/ Huge thanks to Stephanie Lietz, who built the ZeDTech Network from scratch and ran our recent conference at the Francis Crick Institute — now moving on from the team. Thank you for everything!
https://t.co/clhbaDavsf #Dementia #ZeDTech

[Michael David @michaelcbdavid]

New paper out in Alzheimer's & Dementia 🧠 We combined resting-state pupillometry-fMRI, neuromelanin MRI of the locus coeruleus, and cognitive testing in 64 people with Alzheimer's and 26 controls to ask how arousal shapes cortical dynamics in AD. 🧵

[@Neurosharp @Neurosharp]

Pupil-linked arousal tracked synchrony in real time. A weakened arousal system may flatten the brain’s dynamical landscape, raising the possibility that arousal-modulating treatments will be effective treatments. @michaelcbdavid
Open access: https://t.co/jOHo70WHqQ

[@Neurosharp @Neurosharp]

Why does Alzheimer’s disease cause problems with attention?
Attention falters early in AD. Our new paper points to the brain’s arousal system: as the locus coeruleus degenerates, cortical synchrony drops and the brain can’t hold the states attention needs.

[@Neurosharp @Neurosharp]

Could focusing on the noradrenergic system change how we treat Alzheimer's? Led by Michael David with @PareshMalhotra and the CR&T team. #Alzheimers #Dementia #UKDRI

[@Neurosharp @Neurosharp]

New in Alzheimer's & Dementia: using neuromelanin MRI in people with Alzheimer's, locus coeruleus (noradrenaline) integrity tracked AD pathology, symptoms & rate of decline — a possible treatment target. https://t.co/CjSzTteut7

[@Neurosharp @Neurosharp]

The UK DRI Care Research & Technology Centre team showing our Minder technology at the Great Exhibition Road Festival. Great work everybody showing how we can better care for people living with dementia!
The Centre: https://t.co/PgXh6sL8wl
Festival: https://t.co/ua3mm5A4ra

[Adel Helmy @AdelHelmy79]

Many congratulations to @IngaKoerte and Nikolaus Plesnila for an excellent @ENONeurotrauma meeting. Great fun, great hospitality and great scientific programme.

[Danielle Wilson @Daniell19244313]

Can’t believe it’s been a week since our launch of Friend’s of the Care Research & Technology Centre (Friend’s of CR&T), fantastic event bringing together those interested in being at the heart of our research, find out more 👉 https://t.co/psOevLxOTn

[Journal of Neurology, Neurosurgery and Psychiatry @JNNP_BMJ]

Really interesting! Although traumatic brain injury (TBI) is associated with ⬆️ Alzheimer's risk and ⬆️ phospho-tau181, this study shows phospho-tau181 is not elevated in the first year after moderate-to-severe TBI

https://t.co/IOlzrdW960

@nsngraham, @jmschott, @neurosharp

[Danielle Wilson @Daniell19244313]

Fantastic to speak at this years @UKDRI Connectome event about…well….me. Really enjoyed speaking about my path, the wheel of skills and working in the grey (where the magic happens). Finding out about my panel members was an amazing bonus!

[UK Dementia Research Institute @UKDRI]

Super interesting review from @sj_marzi on the application of AI and machine learning in experimental medicine for dementia research👩‍💻👩‍🔬���

Read more in @alzdemjournals👉https://t.co/vHlQSmAWG8

[Simon Mead @smead2]

No big deal - solanezumab targeted soluble monomers the idea being to pull amyloid out of the brain like a sponge - but it didn’t clear amyloid. I really don’t understand why the company pursued it so long I would have dropped years ago (easy to say now)

[Neil Graham @nsngraham]

Pleased to see this comment with @Neurosharp published looking at the great work of the TRACK TBI team on dynamic patient trajectories years post-injury.
More to be done to understand things at a mechanistic level but key implications for patient monitoring & treatment trials.

[Earl K. Miller @MillerLabMIT]

Acetylcholine modulates the temporal dynamics of human theta oscillations during memory
https://t.co/Yo1ukroFEG
#neuroscience

[@Neurosharp @Neurosharp]

Congratulations!

[Mazdak Ghajari @GhajariMazdak]

Reader in Brain Biomechanics @ImperialDyson @imperialcollege since today. Credit to the past and present members of my team and collaborators. Thanks team for the lovely cake.

[Masud Husain @MasudHusain]

This month's @Brain1878 contains a set of important articles on #Parkinsons and #LewyBody dementia, including reviews on alpha-synuclein and bradykinesia, papers on cholinergic loss, mechanisms underlying rigidity, impulse control disorder and cognition https://t.co/7VrjxBlByJ

[Jonathan Schott @jmschott]

So much respect for @englandcricket and @CricketAus for raising awareness of dementia in such a powerful way (and for entertaining us with such wonderful cricket all through this Ashes series)